PROMETHERA Biosciences S.A./N.V. To Present At Several International Partnering And Scientific Conferences This Fall

MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Promethera Biosciences SA, a global innovator in cell-based medicines, today announced that the Company will give presentations at several upcoming scientific and partnering conferences in Asia, Europe and the US including:

CTRMS 2017 - Cell Transplant and Regenerative Medicine Society Meeting
Date: September 26-29, 2017
Venue: Halifax, Nova Scotia, Canada

16^th Sachs Annual Biotech in Europe Forum
Date: September 27-28, 2017
Venue: Basel, Switzerland

2017 Cell & Gene Meeting on the Mesa
Date: October 4-6, 2017
Venue: La Jolla, CA, USA

59^th Annual Meeting of the Japanese Society for Inherited Metabolic Disease
Date: October 14, 2017
Venue: Kawagoe, Japan

10^th Annual Sofinnova Japan Biopharma Partnering Conference
Date: October 24, 2017
Venue: Tokyo, Japan

BIO-Europe 2017 - 23rd Annual International Partnering Conference
Date: November 6-8, 2017
Venue: Berlin, Germany

About Promethera Biosciences

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. We are a team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, and Durham, NC, USA.

Promethera®, HepaStem®, H2stem®, Cytonet®, Heparesc® are all registered trademarks of the PROMETHERA group.